A subscription is required to access all the content in best practice. It is the single most common oncologic emergency and a frequent source of inpatient consultation for nephrologists. Tumor lysis syndrome tls is a lifethreatening medical condition that can occur spontaneously or as a complication of cancer therapy for rapidly proliferating and chemosensitive malignancies. Prevention and management of tumor lysis syndrome in. Hyperphosphatemia may lead to hypocalcemia with resultant tetany or other potentially lifethreatening complications. Recognition and management of tumour lysis syndrome tls. Everything you need to know about tumor lysis syndrome. Choose one of the access methods below or take a look at our subscribe or free trial options. Clinical trial evidence has demonstrated that when the dose escalation and risk management protocol for tls is used, there is a low incidence of tls in patients treated with venetoclax, and that these patients can be robustly managed and their tls. Tumor lysis syndrome tls is a hematologic emergency caused by massive lysis of tumor cells into the blood stream. Spontaneous tumor lysis syndrome in a patient with newly. The nature and severity of the metabolic alterations are variable and may be influenced by the timing and intensity of.
Tumor lysis syndrome tls is an important metabolic disorder frequently encountered in the management of a variety of cancers including lymphoma, leukemia, and neuroblastoma. It typically occurs in patients with lymphoproliferative malignancies who are exposed to chemotherapy, radiation, or corticosteroids, but can occur spontaneously in the absence of treatment. Ards associated with tumor lysis syndrome in a patient. Authors scott c howard 1, deborah p jones, chinghon pui.
The tumor lysis syndrome occurs when tumor cells release their contents into the bloodstream, either spontaneously or in response to therapy. Spontaneous tumor lysis syndrome stls, in the absence of prior chemo or radiation therapy, is rare with solid tumors. Although the vast majority of tls is associated with rapidly proliferating hematologic malignancies, it is often overlooked in solid tumor cases and has only been rarely associated with urothelial carcinomas. The dose of oral allopurinol for tumor lysis syndrome. Tumor lysis syndrome is a potentially life threatening complication of massive cellular lysis in cancers. Nevertheless, a clinician should differentiate tls from other causes of acute kidney injury such as sepsis, obstructive renal disease, medication toxicities including those of chemotherapeutic agentsuse of contrast dye for imaging studies, and rhabdomyolysis, as well as other rarer conditions such as vasculitis and primary glomerulopathies in. The patient was a 55yearold black man with chronic lymphocytic leukemia in whom the tumor lysis syndrome developed after rituximab and bendamustine treatment despite saline and allopurinol. Jan 25, 2021 correction from the new england journal of medicine the tumor lysis syndrome. The case described below illustrates spontaneous tumor lysis syndrome in the context of a rapidly proliferating metastatic colonic adenocarcinoma. We would like to report an additional case recently seen in our facility.
Tumor lysis syndrome after induction chemotherapy in smallcell lung. Preventing and monitoring for tumor lysis syndrome and other. Spontaneous tumor lysis syndrome secondary to smallcell. Rotation prep will no longer be available as part of an individual or institutional subscription to nejm or nejm journal watch. Tumor lysis syndrome and acute anemia in an africanamerican. Tumor lysis syndrome american society of nephrology. Tls is an oncologic emergency caused by the rapid and massive breakdown of tumor cells, either spontaneously or after the initiation of cytoreductive therapy. A pattern of metabolic derangements occurs as a result of a massive release of intracellular contents. Reported incidences of tumor lysis syndrome strati. Tls occurs because of the rapid lysis of proliferating tumor cells. Although it is most frequently associated with the treatment of hematological malignancies, its frequency may be increasing among patients with solid tumors. Tumour lysis syndrome is a complication of chemotherapy for haematological malignancies. Feb 17, 2021 tumor lysis syndrome tls is an oncologic emergency that is caused by massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation.
These criteria systems represent progressive revisions of previous laboratory variables. Catabolism of the nucleic acids to uric acid leads to hyperuricemia, and the marked increase in uric acid excretion can result in the precipitation of uric acid in the renal tubules and can also induce renal vasoconstriction, impaired autoregulation, decreased renal blood flow, and. With increased availability of highly effective cytotoxic thera. Correspondence from the new england journal of medicine the tumor lysis syndrome.
Tumor lysis syndrome is a group of metabolic abnormalities that can occur as a complication during the treatment of cancer, where large amounts of tumor cells are killed off at the same time by the treatment, releasing their contents into the bloodstream. Tumor lysis syndrome, acute kidney injury, acute kidney failure, rasburicase, oncologic emergencies introduction tumor lysis syndrome tls describes the pathological sequela of the rapid lysis of tumor cells. Tumour lysis syndrome in patients with chronic lymphocytic. Howard sc, ribeiro rc, pui ch 2006 acute complications. The recent advancement in cancer treatment has led to the mounting rate of tls in solid tumors that were previously rarely linked to this complication. Allopurinol is a structural analog of hypoxanthine and a competitive inhibitor of xanthine oxidase. Tumor lysis syndrome tls is a lifethreatening medical condition that can occur spontaneously or as a complication of cancer therapy for rapidly proliferating and chemosensitive malignancies such as acute lymphoblastic leukemia or highgrade lymphoma. Tumor lysis syndrome after treatment with docetaxel for nonsmallcell lung cancer. Cambridge university press, cambridge, pp 709749 4. Tumor lysis syndrome tls is an oncologic emergency characterized by lifethreatening metabolic disturbances.
Tumour lysis syndrome symptoms, diagnosis and treatment. Tumor cytotoxicity releases intracellular contents, including nucleic acids, proteins, and electrolytes into the systemiccirculation and may lead to development of hyperuricemia, hyperphosphatemia, hy. Tumor lysis syndrome tls is a potential emergent complication of oncologic treatment. Ards developed in association with tumor lysis syndrome tls in a patient with nonhodgkins lymphoma. In the middle column of table 1 page 1846, the value for ionized calcium in the hypocalcemia row should have been tumor lysis syndrome tls is a constellation of metabolicabnormalitiesresultingfromeitherspontaneousorchemotherapyinducedtumorcelldeath. The devastating outcomes of tls arise from rapid tumor cell lysis and the release of metabolites into the systemic circulation, therefore. It is characterized by hyperuricemia, hyperphosphatemia, hypocalcemia, hyperkalemia and development of uric acid nephropathy, oliguria, acute kidney injury aki and, in severe cases, seizures, cardiac arrhythmias and death. Daniel brunnhoelzl1 and jue wang 1creighton university school of medicine at st.
Introduction tumor lysis syndrome tls is a common, but lifethreatening oncological emergency that frequently requires inpatient management. Ibrutinib plus venetoclax for the treatment of mantlecell lymphoma. Tumor lysis syndrome tls is a constellation of metabolic abnormalities resulting from either spon taneous or chemotherapyinduced tumor cell death. The syndrome consists of laboratory abnormalities either alone laboratory tls or with clinical sequelae including renal failure, seizures, and arrhythmias clinical tls. A case of tumor lysis syndrome induced by surgery in colon. Tls comprises laboratory derangements hyperuricaemia, hyperkalaemia, hyperphosphataemia, and hypocalcaemia responsible for acute kidney injury.
Tls is most frequently a result of cancer treatment in combination with a large tumor burden, but has occasionally been reported to occur spontaneously, especially in cases of. Usually occurs in patients with bulky, rapidly proliferating, and. Tumor lysis syndrome tls, a potential complication of cancer treat ment, occurs. Acute tumor lysis syndrome after antipd1 immunotherapy nivolumab for metastatic melanoma.
Lusis search methodology was adapted from the scientific search guidelines published in 5. Tls is characterized by the release of potassium, phosphorous, and nucleic acids from cancer cells into the blood stream, with the potential to cause hyperkalemia. Practical management of tumour lysis syndrome in venetoclax. Lysis tumor syndrome nejm pdf correction from the new england journal of medicine the tumor lysis syndrome. Tumor lysis syndrome tls in adult patients page 2 of 7 disclaimer. Here, we present a case of stls secondary to a smallcell neuroendocrine tumor of unknown origin in a 66yearold female patient who presented with abdominal discomfort. The pathophysiology of altered calcium metabolism in rhabdomyolysis induced acute renal failure. Clinical tls is a predictor for worse overall morbidity and mortality in cancer patients, but can be prevented. Tumor lysis syndrome in small cell carcinoma and other solid. Josephs hospital and medical center, phoenix, az, usa accepted on 27 february, 2017.
With venetoclaxbased treatment, there is a requirement to follow the established guidelines for close monitoring during initiation and ramp up, to reduce the risk of tumor lysis syndrome. Tumor lysis syndrome and metastatic melanoma springerlink. Although a number of lifethreatening complications have been noted to occur following tls, this appears to be the first report of ards developing in association with tls. Dec 04, 2020 two different treatment approaches have evolved. The tumor lysis syndrome nejm new england journal of. Correction from the new england journal of medicine the tumor lysis syndrome. Josephs hospital and medical center, phoenix, az, usa 2university of arizona cancer center at dignity health st.
Tls is commonly reported in hematological malignancies with rapid cell turnover rates, but is relatively rare in solid tumors. Tumor lysis syndrome in nonhematologic malignancies. Tumor lysis syndrome is a massive lysis of malignant cells due to quick proliferation, and it is characterized by hyperuricemia, hyperkalemia, and hyperphosphatemia. For haematological malignancies, targeted therapies, such as small molecule inhibitors and monoclonal antibodies, have a high antitumour activity, are well tolerated, and have a low incidence of associated tumour lysis syndrome. The shift of potassium, phosphorus, and nucleic acid material into the extracellular space can rapidly overcome existing ho. Tumor lysis syndrome tls in adult patients page 1 of 7 disclaimer. This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular to md andersons specific patient population, services and structure, and clinical information. In some patients, tumor lysis results in acute renal failure. Tumour lysis syndrome tls is a significant complication of haematologic malignancies and their management. Tumor lysis syndrome tls is a constellation of laboratory and clinical manifestations that can occur spontaneously or after the start of therapy.
Everything you need to know about tumor lysis syndrome tl. Howard sc, jones dp, pui ch 2011 the tumor lysis syndrome. Pdf diagnosis and management of tumor lysis syndrome. Acute tumor lysis syndrome in patients with highgrade nonhodgkins lymphoma. To reduce the risk of the tumor lysis syndrome, all patients commenced treatment with ibrutinib. Pdf steroidinduced tumor lysis syndrome in a patient with. Tumor lysis syndrome and acute anemia in an african. This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular to md andersons specific patient population, services and structure. Nov 20, 2020 tumor lysis syndrome is a clinical condition that can occur spontaneously or after initiation of chemotherapyassociated with the following metabolic disorders. Tumor lysis syndrome tls is an acute, lifethreatening disease among adults and children that is associated with the initiation of cytoreductive therapy in the treatment of malignancy. Identification of highrisk patients and early recognition of.
Adapted from 1 holdsworth, ajhp, 2003 and 2 howard, nejm, 2011. Computed tomography ct abdomen showed a large tumor mass with peritoneal metastasis, and she developed. Tumor lysis syndrome tls is a well described oncologic emergency. Tumor lysis syndrome tls is a lifethreatening oncological condition that is typically characterized by metabolic derangements that are often labeled as an acute kidney injury. Tumor lysis syndrome a 1 tls is a metabolic disorder that results from the rapid. May 10, 2020 tumor lysis syndrome is one important complication that pharmacists should be knowledgeable about as part of the patient care team.
Guidelines for the management of pediatric and adult tumor lysis syndrome. Aug 26, 2020 tumour lysis syndrome tls is an oncological emergency characterised by metabolic and electrolyte abnormalities that can occur after the initiation of any cancer treatment, but can also occur spontaneously. The tumor lysis syndrome is the most common diseaserelated emergency in children and adults with hematologic cancers. Given that its prognosis is dismal, it is essential to increase. Tumor lysis syndrome and collateral immune activation in. A pattern of metabolic derangements occurs as a result of a massive release of intracellular contents into the systemic circulation. Tumor lysis syndrome refers to the metabolic disturbances hyperuricemia, hyperphosphatemia, hyperkalemia, and hypocalcemia associated with lymphoproliferative malignancies which occur secondary to cell lysis. Tumor lysis syndrome tls is a serious, sometimes lifethreatening oncologic emergency caused by rapid and massive cellular lysis and subsequent release of tumor cell contents and cytokines into. Tumor lysis syndrome tls was first described in 1929 by bedrna and polcak in patients with chronic leukemia. Tumor lysis syndrome is a medical emergency that, without prompt intervention, can result in significant morbidity related to cardiac arrhythmias, seizures, renal failure, and possibly death. Tumor lysis syndrome tls in adult patients page 1 of 7. Tumor lysis syndrome tls is a potentially lifethreatening metabolic disorder that occurs when tumor cells undergo rapid decomposition spontaneously or in response to cytoreductive therapy. Acute tumor lysis syndrome in the absence of cytotoxic therapy is an uncommon event but has been reported with hematologic malignancies. Tumour lysis syndrome tls is a set of metabolic disorders and a consequence of the rapid release of intracellular components such as potassium, phosphates, nucleic acids, proteins and their metabolites into the bloodstream as a result of the massive destruction of a tumour population.
Tumor lysis syndrome slt is a rare and potentially fatal entity. It is necessary to mention that phosphate binders may be used in patients with hyperphosphatemia in the tls setting. Here, we report the rare case of a 70year old man with colon cancer and extensive liver involvement manifesting with tls following surgery. Background tumor lysis syndrome tls results from massive lysis of rapidly proliferating malignant cells, and is characterized by hyperuricemia, hyperkalemia, and hyperphosphatemia. Tumor lysis syndrome associated with urothelial cancer. Tumor lysis syndrome tls in pediatric patients page 1 of 6. Tumor lysis syndrome tls is an oncologic emergency with limited treatment options. Acute kidney injury developed in our patient as a result of the precipitation of uric acid crystals and calcium phosphate crystals and was exacer. The syndrome is deemed spontaneous when it occurs before initiation of any cytotoxic or definitive treatment. Here you will find an overview of this cancer complication along with prevention and treatment strategies.
These systems identified variables to define laboratory indications of tumour lysis syndrome, in which metabolic and electrolyte alterations are observed without any clinical symptoms, and clinical tumour lysis syndrome, in which the laboratory alterations are severe enough to produce clinical manifestations, most notably affecting renal, cardiac, and neuromuscular systems. Use of sodium bicarbonate for alkalinization of urine is currently not recommended for prevention and treatment of tumor lysis syndrome tls. Clinical tumor lysis syndrome is present when laboratory tumor lysis syndrome is accompanied by an increased. Department of clinical effectiveness v3 approved by the executive committee of the medical staff on 01192021 tumor lysis syndrome tls in adult patients page 2 of 7 disclaimer. Venetoclax and obinutuzumab in patients with cll and coexisting.
1633 1828 414 1621 63 1770 1711 655 1124 1507 84 760 1057 1793 569 717 1005 1278 239 328 733 1794 990 597